Navigation Links
Cyberonics to Present at UBS Global Life Sciences Conference
Date:9/10/2009

HOUSTON, Sept. 10 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 22, 2009 at 4:00 PM EDT. UBS will host a webcast of the presentation live and by replay at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=82_IT8KY1C. The replay will be available for 90 days following the conference. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Tuesday, September 22, 2009. The presentation can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.<
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
4. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
5. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
6. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
7. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
8. Cyberonics to Present at UBS Global Life Sciences Conference
9. Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike
10. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
11. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...E,Tenn.,Nov.23/PRNewswire/--HealthLeaders-InterStu...,reportsthatself-insuredmembercompaniesthatarepart...danaggregatehealthcare-costdecreaseof1.5percentper...ninahigh-performanceprovidernetwork.Accordingtothe...lf-insuredmembercompaniessaved$44millioninhealthca...
(Date:11/23/2009)...HOOT15MILLIONFREETHROWSIN2010WORLD,SLARGESTFREETHR....S.TOUR&TRIPTOAFRICANEXTYEAR ,, WORLDVISI...,, SEATTLE,Nov.23/PRNewswire-USNewswire/--Nextw...usandsnationwidewilltakepartin HoopsofHope ,thewor...hemovementis15-year-old AustinGutwein fromMesa,Ari...
(Date:11/23/2009)....23/PRNewswire-FirstCall/-- ,, DearIsisSupporte...ngyouforyourcontinuingsupportofIsis.Webelieveweare...rulyattheendofthebeginningofcreatingauniquecompany...essesmanyoftheissueshauntingthepharmaceuticalindus...ccessofourflagshipdrug,mipomersen.Mipomersencontin...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--NewCardio,Inc.,(OTCBu...der,announcedtodaythatCEO,Dr.BranislavVajdic,andCF...ROConferenceonThursday,December3rd,at4:30PMPSTatth...entwillbeavailableforone-on-onemeetingsonWednesday...rettAimeeMaasat(646)536-7331or brett@haydenir.com ...
(Date:11/23/2009)...swire/--TheBerylCompanies,thenation,sleadingprovid...dustry,hasearnedrecognitionasoneofthetopoutsourcin...,sleadingtrademagazine.Berylwasrankedamongthepubli...inessresults,whichenabledittoclimbfromtwelfthplace...htoitsinnovativeproducts,suchasitsnewestlaunchofpo...
Breaking Medicine News(10 mins):Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2
...nis Giesing, Chief Scientific,Officer and Terry Ni...als,Inc. (OTC Bulletin Board: URGP) (http://www.u...view with http://www.wallst.net scheduled for No...ncluding Urigen Pharmaceutical,s,market potential,...
...spinal damage most common reasons for ER visits, s...y News) -- While riding an all-terrain vehicle (AT...o often it can end in a serious injury and a trip ...t the most common injuries that youngsters sustain...
... 2007) Rutgers College of Nursing faculty member ... of the Rutgers-Newark Provosts Award for Communit...ch of broad scholarly significance based in whole ...ement to acknowledge the valuable relationships Ru...
...p Global Health,Inc. (OTC Bulletin Board: FGHH) wi... November 29, 2007. Mr. Fred Nazem, Chairman, and ...will host the investor call and will be,giving a d...s toll free, (866) 566-1240 (domestic) and (702),4...
...ology allows medical professionals to instantly ..., WESTCHESTER, Ill., Nov. 26 BrainLAB, a global ...ss-invasive medical treatments,today showcased one...of a traditional hospital lightbox with the,featur...
...26 American,Physicians Capital, Inc. (Nasdaq: AC...d its $15 million authorization approved by its Bo...ionary stock repurchase program,which had approxim...ts Board of Directors on August 16, 2007., "I am ...
Other Medicine News:Health News:WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals 2Health News:ATV Injuries on the Rise 2Health News:ATV Injuries on the Rise 3Health News:Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 3Health News:American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program 2Health News:American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program 3
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall...ced results for its first quarter ended September ...er diluted share, on revenues of $3,263,000. This...r diluted share, on revenues of $3,168,000 for the...he first quarter results, Biotel President and CEO...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , ARDEE, Ireland, Nov. 19 ...ed the pricing of its previously announced seconda...t a price to the public of $22.25 per share. The ... Bain Capital Partners, DLJ Merchant Banking, J.P....mas H. Lee Partners, L.P., certain other instituti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...uticals, Inc.,announced today that a new analysis ... Biomedical Research Institute at Harbor-UCLA Medi...of hypogonadal men with AndroGel(R),(testosterone ...rdless of,weight and body mass index (BMI). These ...ocrine Society Annual Meeting (ENDO) in San Franci...
...ONE MINERAL DENSITY, SAN DIEGO, June 17 Neurocri...ay that the elagolix 0603 Phase IIb trial,(Petal S...he last subject,completed her Week 24 study visit ...mpact of elagolix treatment on bone mineral densit...X-ray Absorptiometry (DXA) scans to,document any c...
Other Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 2Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 3
Lambda Fluoro 320
DELFIA Platewash
SkanStacker (110V)
...he Labcyte miniGene LW is a new plate washing syst...96 and 384 channel microplates with flat, V-shaped...with 8 or 16 channel nozzle heads. Simple LCD touc...ional plate stacker is available for the miniGene ...
Medicine Products: